Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Arya Sciences Acquisition Corp IV Cl A (NQ: ARYD )

6.640 UNCHANGED
Last Price Updated: 3:59 PM EDT, Jul 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 6.640
Bid (Size) 7.500 (1)
Ask (Size) 8.600 (1)
Prev. Close 6.640
Today's Range 6.640 - 6.640
52wk Range 6.640 - 11.57
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Adagio Medical Announces the Closing of the Business Combination with ARYA IV, Creating a Publicly Traded Company Focused on the Innovative Technologies for Treatment of Cardiac Arrhythmias
From Adagio Medical, Inc.
Via Business Wire
Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider
From GENENTA SCIENCE SPA
Via GlobeNewswire

Performance

YTD
-39.25%
-39.25%
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
-41.60%
-41.60%
1 Year
-38.80%
-38.80%

More News

Read More
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Gene Therapy Player Amicus Therapeutics Terminates SPAC Merger, Shares Fall
Via Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
Via Benzinga
The Week In SPAC News - Sunday, Oct. 3
Via Talk Markets
Perceptive Advisors-Backed SPAC To Acquire Amicus's Gene Therapy Business
Via Benzinga
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
Via Benzinga
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.